annual EBITDA:
$226.96M+$483.08M(+188.61%)Summary
- As of today (June 22, 2025), CVAC annual EBITDA is $226.96 million, with the most recent change of +$483.08 million (+188.61%) on December 31, 2024.
- During the last 3 years, CVAC annual EBITDA has risen by +$684.24 million (+149.63%).
- CVAC annual EBITDA is now at all-time high.
Performance
CVAC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$49.19M-$11.99M(-32.24%)Summary
- As of today (June 22, 2025), CVAC quarterly EBITDA is -$49.19 million, with the most recent change of -$11.99 million (-32.24%) on March 1, 2025.
- Over the past year, CVAC quarterly EBITDA has increased by +$21.07 million (+29.99%).
- CVAC quarterly EBITDA is now -111.92% below its all-time high of $412.68 million, reached on September 30, 2024.
Performance
CVAC quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$255.27M+$21.07M(+9.00%)Summary
- As of today (June 22, 2025), CVAC TTM EBITDA is $255.27 million, with the most recent change of +$21.07 million (+9.00%) on March 1, 2025.
- Over the past year, CVAC TTM EBITDA has increased by +$524.25 million (+194.90%).
- CVAC TTM EBITDA is now at all-time high.
Performance
CVAC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
CVAC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +188.6% | +30.0% | +194.9% |
| 3 y3 years | +149.6% | -951.2% | +175.2% |
| 5 y5 years | +321.6% | -119.1% | +405.6% |
CVAC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +149.6% | -111.9% | +62.3% | at high | +175.2% |
| 5 y | 5-year | at high | +149.6% | -111.9% | +71.7% | at high | +149.3% |
| alltime | all time | at high | +149.6% | -111.9% | +71.7% | at high | +149.3% |
CVAC EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$49.19M(+32.2%) | $255.27M(+9.0%) |
| Dec 2024 | $226.96M(-188.6%) | -$37.19M(-109.0%) | $234.20M(+27.3%) |
| Sep 2024 | - | $412.68M(-681.0%) | $183.97M(-167.0%) |
| Jun 2024 | - | -$71.02M(+1.1%) | -$274.61M(+2.1%) |
| Mar 2024 | - | -$70.25M(-19.6%) | -$268.98M(+6.3%) |
| Dec 2023 | -$256.13M(+8.9%) | -$87.42M(+90.4%) | -$253.09M(-14.6%) |
| Sep 2023 | - | -$45.91M(-29.8%) | -$296.19M(+1.8%) |
| Jun 2023 | - | -$65.39M(+20.3%) | -$290.98M(+4.6%) |
| Mar 2023 | - | -$54.36M(-58.4%) | -$278.21M(+21.7%) |
| Dec 2022 | -$235.30M | -$130.52M(+220.7%) | -$228.53M(+133.4%) |
| Sep 2022 | - | -$40.70M(-22.6%) | -$97.89M(-55.2%) |
| Jun 2022 | - | -$52.62M(+1024.6%) | -$218.54M(-35.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$4.68M(-4361.6%) | -$339.56M(-26.5%) |
| Dec 2021 | -$457.28M(+312.5%) | $109.80K(-100.1%) | -$462.20M(-10.7%) |
| Sep 2021 | - | -$161.35M(-7.1%) | -$517.45M(+31.1%) |
| Jun 2021 | - | -$173.65M(+36.4%) | -$394.56M(+76.0%) |
| Mar 2021 | - | -$127.32M(+130.9%) | -$224.23M(+87.9%) |
| Dec 2020 | -$110.86M(+8.2%) | -$55.14M(+43.4%) | -$119.36M(+13.0%) |
| Sep 2020 | - | -$38.46M(+1059.3%) | -$105.61M(+21.6%) |
| Jun 2020 | - | -$3.32M(-85.2%) | -$86.86M(+4.0%) |
| Mar 2020 | - | -$22.45M(-45.7%) | -$83.54M(+0.3%) |
| Dec 2019 | -$102.44M(+29.3%) | -$41.38M(+110.0%) | -$83.26M(+98.8%) |
| Sep 2019 | - | -$19.71M(-11.1%) | -$41.87M(+88.9%) |
| Mar 2019 | - | -$22.17M | -$22.17M |
| Dec 2018 | -$79.20M | - | - |
FAQ
- What is CureVac NV annual EBITDA?
- What is the all time high annual EBITDA for CureVac NV?
- What is CureVac NV annual EBITDA year-on-year change?
- What is CureVac NV quarterly EBITDA?
- What is the all time high quarterly EBITDA for CureVac NV?
- What is CureVac NV quarterly EBITDA year-on-year change?
- What is CureVac NV TTM EBITDA?
- What is the all time high TTM EBITDA for CureVac NV?
- What is CureVac NV TTM EBITDA year-on-year change?
What is CureVac NV annual EBITDA?
The current annual EBITDA of CVAC is $226.96M
What is the all time high annual EBITDA for CureVac NV?
CureVac NV all-time high annual EBITDA is $226.96M
What is CureVac NV annual EBITDA year-on-year change?
Over the past year, CVAC annual EBITDA has changed by +$483.08M (+188.61%)
What is CureVac NV quarterly EBITDA?
The current quarterly EBITDA of CVAC is -$49.19M
What is the all time high quarterly EBITDA for CureVac NV?
CureVac NV all-time high quarterly EBITDA is $412.68M
What is CureVac NV quarterly EBITDA year-on-year change?
Over the past year, CVAC quarterly EBITDA has changed by +$21.07M (+29.99%)
What is CureVac NV TTM EBITDA?
The current TTM EBITDA of CVAC is $255.27M
What is the all time high TTM EBITDA for CureVac NV?
CureVac NV all-time high TTM EBITDA is $255.27M
What is CureVac NV TTM EBITDA year-on-year change?
Over the past year, CVAC TTM EBITDA has changed by +$524.25M (+194.90%)